FY2025 · period end Dec '25 · from the 10-K filed Mar 2, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $0.90B | $0.78B | $0.56B | $0.39B | $0.26B |
| Gross Profit | $0.40B | $0.39B | $0.28B | $0.18B | $0.11B |
| Operating Income | $0.11B | $0.15B | $0.10B | $0.06B | $0.04B |
| Net Income | $0.09B | $0.10B | $0.08B | $0.04B | $0.04B |
| EPS (Diluted) | $1.37 | $1.53 | $1.16 | $0.59 | $0.58 |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $2.87B | $1.86B | $1.49B | $1.24B | $1.05B |
| Total Liabilities | $0.94B | $0.76B | $0.56B | $0.42B | $0.24B |
| Stockholders' Equity | $1.93B | $1.10B | $0.93B | $0.81B | $0.81B |
| Cash & Equivalents | $0.76B | $0.41B | $0.18B | $0.25B | $0.56B |
| Total Debt | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | negative: -$0.01B | $0.15B | negative: -$0.08B | negative: -$0.06B | negative: -$0.04B |
| Capital Expenditures | $0.06B | $0.08B | $0.06B | $0.09B | $0.01B |
| Free Cash Flow | negative: -$0.07B | $0.07B | negative: -$0.14B | negative: -$0.15B | negative: -$0.05B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 44.4% | 50.1% | 49.5% | 47.2% | 44.2% |
| Operating Margin | 0.1% | 0.2% | 0.2% | 0.2% | 14.9% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 14.5% |
| Return on Equity | 6.2% | 10.2% | 8.9% | 4.8% | 4.7% |
| Return on Assets | 4.0% | 6.2% | 5.7% | 3.4% | 3.6% |
| Debt / Equity | 0.15× | 0.17× | 0.10× | 0.09× | — |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001628280-26-059251 | Aug 17, 2026 | Aug 27, 2026 | Aug 27, 2026 20:05 UTC | EDGAR |
| 8-K | 0001628280-26-054581 | Aug 7, 2026 | Aug 7, 2026 | Aug 7, 2026 11:37 UTC | EDGAR |
| 10-Q | 0001628280-26-054832 | Jun 30, 2026 | Aug 7, 2026 | Aug 7, 2026 20:07 UTC | EDGAR |
| 8-K | 0001628280-26-044506 | Jun 18, 2026 | Jun 22, 2026 | Jun 22, 2026 13:11 UTC | EDGAR |
| 8-K | 0001628280-26-042833 | Jun 10, 2026 | Jun 12, 2026 | Jun 12, 2026 20:06 UTC | EDGAR |
| 8-K | 0001140361-26-023310 | May 26, 2026 | May 29, 2026 | May 29, 2026 20:01 UTC | EDGAR |
| 8-K | 0001628280-26-037552 | May 19, 2026 | May 22, 2026 | May 22, 2026 12:46 UTC | EDGAR |
| 8-K | 0001140361-26-021661 | May 15, 2026 | May 15, 2026 | May 15, 2026 20:16 UTC | EDGAR |
Direct links to SEC EDGAR. ACMR has additional filings available on the SEC site.
6 numbers ACM Research, Inc. later changed — same XBRL tag, both filings linked.
Net Cash Provided by (Used in) Operating Activities·Q2 2023
Major restatementwas-$24.2M
Revised up in a 10-Q.
Net Income (Loss) Attributable to Parent·Q3 2020
Major restatementwas$10M
Revised down in a 10-Q. Any P/E built on the original was 16.1% too low.
Net Cash Provided by (Used in) Operating Activities·Q3 2023
Major restatementwas-$42.1M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Operating Activities·Q3 2022
Notable restatementwas-$63.5M
Revised up in a 10-Q.
Net Cash Provided by (Used in) Investing Activities·Q3 2023
Major restatementwas-$2.1M
Revised down in a 10-Q.
Net Cash Provided by (Used in) Investing Activities·Q2 2023
Major restatementwas$46.6M
Revised down in a 10-Q.
ACMR is not the only one.
See every restatement we've found across the market — or get an alert the next time ACMR revises a number.
Restatements are detected by comparing every vintage of a fact across all of ACM Research, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ACMR's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling ACM Research, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ACMR yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on ACMR and publish the result to your public profile.
Ask about ACM Research, Inc.
Continue in Workspace — cited answers on ACMR, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs